IL5RA and asthma: The epigenetic finding allowed the study and incorporation of the monoclonal antibody Benralizumab21 (Anti-IL-5Ra) in clinical practice, a drug that binds to IL5RA, inducing a reduction in exacerbations and improvement in lung function in patients with severe asthma.4